Neoadjuvant treatment sequencing adds value to the care of patients with operable pancreatic cancer

Medientyp: E-Artikel
Titel: Neoadjuvant treatment sequencing adds value to the care of patients with operable pancreatic cancer
Beteiligte: Asare, Elliot A.; Evans, Douglas B.; Erickson, Beth A.; Aburajab, Murad; Tolat, Parag; Tsai, Susan
Erschienen: Wiley, 2016
Erschienen in: Journal of Surgical Oncology
Sprache: Englisch
DOI: 10.1002/jso.24316
ISSN: 0022-4790; 1096-9098
Schlagwörter: Oncology ; General Medicine ; Surgery
Entstehung:
Anmerkungen:
Beschreibung: <jats:sec><jats:label /><jats:p>Treatment sequencing for resectable pancreatic cancer remains controversial and there is lack of level one evidence comparing neoadjuvant versus adjuvant strategies. However, a comparison of the cost‐effectiveness analysis of the treatment strategies may help to better define the healthcare value of each approach. This review will highlight the rationale for multimodality therapy in the treatment of pancreatic cancer, discuss the advantages and disadvantages of adjuvant therapy, and conceptualize the cost‐effectiveness of a neoadjuvant approach with regard to healthcare value. <jats:italic>J. Surg. Oncol. 2016;114:291–295</jats:italic>. © 2016 Wiley Periodicals, Inc.</jats:p></jats:sec>

Nur in Feld suchen: